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Many patients experience pain and discomfort after colonoscopy. Carbon dioxide (CO2) can reduce periprocedural pain although
airinsuﬄationremainedthestandardprocedure. Theobjective ofthisdouble-blinded, randomizedcontrolledtrialwastoevaluate
whether CO2 insuﬄation does decrease pain and bloating during and after colonoscopy compared to room air. Methods. 219
consecutive patients undergoing colonoscopy were randomized to either CO2 or air insuﬄation. Propofol was used in all patients
forsedation.Transcutaneous CO2 wascontinuously measured with a capnographasa safetyparameter. Pain,bloating,and overall
satisfaction were assessed at regular intervals before and after the procedure. Results (data are mean ±SD). 110 patients were
randomized to CO2 and 109 to room air. The baseline characteristics were similar in both groups. The mean propofol dose was
notdiﬀerentbetween thetreatments,aswerethetimetoreach theileumandthewithdrawaltime.pCO2 attheendoftheprocedure
was 35.2 ± 4.3mmHg (CO2 group) versus 35.6 ± 6.0mmHg in the room air group (P>. 05). No relevant complication occurred
in either group. There was signiﬁcantly less bloating for the CO2 group during the postprocedural recovery period (P<. 001) and
over the 24-hour period (P<. 001). Also, patients with CO2 insuﬄation experienced signiﬁcantly less pain (P = .014). Finally, a
higher overall satisfaction (P = .04 ) was found in the CO2 group. Conclusions. This trial provides compelling evidence that CO2
insuﬄation signiﬁcantly reduces bloating and pain after routine colonoscopy in propofol-sedated patients. The procedure is safe
with no signiﬁcant diﬀerences in CO2 between the two groups.
1.Introduction
Many patients experience pain and discomfort after colono-
scopy. An explanation for this observation is the retention
of gas in the colon, as several liters of air are insuﬄated
during colonoscopy. For decades, CO2 insuﬄation has
been routinely used to create the pneumoperitoneum in
lapraroscopic surgery. Conversely, room air insuﬄation has
remained the standard of care in most endoscopy centres
[1]. Preliminary studies indicate that insuﬄation of carbon
dioxide(CO2)mayreduceperiproceduralpain.CO2 was ﬁrst
recommended 1953 to avoid gas combustion in the colon
during electrocoagulation [2]. In 1986, the rapid absorption
of CO2 in the colon and minimal interference with colonic
circulation were described, therefore minimizing the risk of
bowel ischemia [3]. CO2 is absorbed about 150 times faster
compared to nitrogen and is rapidly eliminated through the
lungs [4]. Interestingly, 30 minutes after insuﬄation with
CO2,thegashasdisappeared, whereaspatientswith standard
room air insuﬄation still have a signiﬁcant distension of
both small bowel and colon [5]. Initial studies with a limited
number ofpatientshave suggested potential beneﬁtsforCO2
use: Sumanac et al. [6] examined 97 patients undergoing
colonoscopy with either CO2 or room air insuﬄation and
showed that 45% of the patients examined with room air
hadpainonehourafterexamination comparedwithonly9%
in the CO2 insuﬄation group. Six hours after colonoscopy,
the fraction of patients with pain was 31% in the room
air group versus 7% in patients with CO2 insuﬄation.
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than 6cm in diameter in 71% of patients assigned to room
air compared with only 4% in the CO2 group [6]. Similarly,
in the NORCCAP, a Norwegian colorectal prevention study
[7], 267 patientsunderwent colonoscopy with insuﬄation of
either room air or CO2, with the latter group experiencing
less postprocedural pain. With recent new developments
that facilitate the use of CO2, more data have become
available supporting the observation that insuﬄation with
CO2 causeslesspain [8–10] .T h es a m ec o n c l u s i o nw a sd ra wn
in the review of Dellon et al., which included 8 randomized
controlled trials (RCTs) with two RCTs showing decreased
ﬂatus and 3 decreased bowel distension on abdominal
radiography [11].
A large, population-based survey based on 7,370 colono-
scopies performed in Norwegian endoscopy centers revealed
that up to 24% of patients experience severe pain during
colonoscopy [12]. According to one study, 20% of patients
need more than two days before being able to return to
their normal activities after screening colonoscopy [13].
These ﬁndings demonstrate that there exists a tremendous
potential for improvement towards painless colonoscopy.
In addition to better periprocedural pain control, anoth-
er potential beneﬁt of CO2 use is that no gas aspiration is
necessary during withdrawal due to the fast gas absorption.
Better colonic insuﬄation may be associated with a better
diagnostic yield and especially a higher polyp detection rate.
Comfort during and after colonoscopy represents a major
issue for patient tolerance and acceptance. It is imperative
that the nowadays recommended longer withdrawal times,
and consecutively longer insuﬄations, do not compromise
patient comfort. It would be wrong to shorten the with-
drawal time during colonoscopy to make concessions with
respect to patient comfort.
The objective of the present randomized controlled
double-blinded trial was to assess patient satisfaction, pain,
and bloating between patients undergoing colonoscopy with
CO2 insuﬄation versus standard room air.
2.PatientsandMethods
In this randomized controlled trial, 219 consecutive patients
undergoing colonoscopy in a private Swiss gastroenterology
practice were enrolled between April 2008 to June 2008
(only one patient did not participate in this time period).
Patients were randomly assigned to colonoscopy with either
CO2 versus room air insuﬄation. This randomized trial was
double blinded, as neither the patients nor the gastroen-
terologist were aware ofthe intervention. The randomisation
w a sd o n ew i t had i c ef o re a c hp a t i e n t .I ft h en u m b e r
was even, the patient underwent colonoscopy with CO2,i f
the number was uneven, colonoscopy with room air. The
study nurse, without any involvement of the investigator,
did the selection. The ethical committee approved the trial,
and written patient consent was obtained for each patient
for colonoscopy and for the study receiving patient study
information includingan informed consentsection ona visit
prior to the scheduled colonoscopy.
All patients that seemed medically ﬁt for an ambulatory
colonoscopy were enrolled in this study. No particular
exclusion criteria were used to maximize the generalizability
(external validity) of this study. All colonoscopies were
done by the ﬁrst author and carried out with standard
Pentax endoscopes (EC-3885K and EC-380FKp) with a
standard processor EPK 1000. For CO2 insuﬄation, the
medical licensed and approved CO2-Eﬃcent Insuﬄator
device (EZEM company Westbury NY 11590, US) was used.
This insuﬄator is connected to a 10L CO2 bottle. The CO2
is then supplied over a tubing set connected with a branch
connection to the water bottle tube directly connected to the
endoscope. The ﬂow rate (basal ﬂow rate 0.5L per minute
increasing to 3L per minute if necessary) can be controlled
on demand over the standard air valve. Air supply with the
Pentax processor or CO2 insuﬄation with the CO2 Eﬃcent
Insuﬄator cannot be acoustically discriminated. The valves
for the endoscope using CO2 are identical with the standard
valves. Moreover, the switch for the pump of the CO2
processor was hidden as was the switch for the insuﬄator.
The front line of the processor and the CO2 insuﬄator
were covered to mask the operational status. The setup
was done by the assisting nurse prior to the start of the
colonoscopy without knowledge of the examiner. Therefore,
this was a truly double-blinded trial. All patients were
sedated with propofol using standard procedures previously
described [14]. A level of conscious sedation (now classiﬁed
as moderate sedation) was targeted giving propofol boli of
10 or 20mg according to ASA-Classiﬁcation. The total dose
of propofol was registered and used for later analysis.
The primary endpoint of the present investigation was
overall pain scores. Secondary endpoints were bloating as
well as overall satisfaction assessed on a 10-point visual
analogue scale (VAS) before and after the examination at 1,
3, 6, and 24 hours.
The grading of the VAS were as follows: for pain: 0 = no
pain at all, 10 = worst possible pain; for bloating: 0 = no
bloating at all, 10 = terrible bloating; for satisfaction: 0 = not
at all satisﬁed, 10 = perfectly satisﬁed.
Asqualityindicatorsandcharacteristics oftheperformed
colonoscopytimetoreachtheileum,withdrawal time,length
of intervention, procedural length, and the number and the
size (>1cm,<1cm, small polyp <5mm) of removed polyps
and their histology were assessed. Finally, periprocedural
complications were registered as well as time to discharge,
propofol dosage, oxygensupply,and other medicationgiven.
We also continuously measured transcutaneous carbon
dioxide with a Sentec Capnograph device (SenTec AG 4106
Therwil, Switzerland) for respiratory monitoring.
The patients were motivated at discharge to ﬁll out
the postprocedure survey regarding pain, bloating, and
satisfaction. We purposefully and a priori decided not to
call any patients who did not mail in the survey, as this
would have potentially led to imprecise results from patients
retrospectively ﬁlling out the survey.
2.1.Statistics. Statisticalanalyses were performed using SPSS
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P<. 05. To compare dichotomous (yes/no) and categorical
outcomes, the Chi Square test was used. For comparisons of
continuous outcomes, unpaired t-tests were used.
The sample size computationswere based on a diﬀerence
for overall pain scores (the primary endpoint) with an eﬀect
size of 2 (overall pain score of 4 in the CO2 group versus 6
in the room air group). With a power of 80% (beta error of
20%), type I error of 5%, and standard deviation of 5, the
resulting sample size was 200 patients.
3.Results
A total number of 219 patients undergoing colonoscopy
were enrolled in this study. One hundred and ten patients
were randomized to the CO2 group and 109 to the room
air group. The baseline characteristics of both groups are
displayed in Table 1. These baseline characteristics were
similar in both groups with the exception of gender and the
fractionofpatientswithirritablebowelsyndrome:therewere
signiﬁcantly more women (62% versus 47%, P = .03) and
IBS patients in the CO2 group (Table 1).
The duration to reach the ileum was 7.7±4.7 minutes in
the CO2 groupand 6.7±4.1in the room air group (P>. 05).
Withdrawal times were 13.6 ± 6.0 minutes in the CO2 group
and 13.3 ± 6.1 minutes in the room air group (P>. 05).
Outcomes are listed in Table 2. In 10.9% of the patients
in the CO2 group, relevant polyps were removed (relevant
polyps were deﬁned as by size over 1cm, histology (e.g.,
villous and serrated) or by high grade dysplasia). In the air
group, the corresponding percentage was 7.3%. Additional
adenomas (smaller than 1cm) were found in 34.5% versus
33.9%, respectively (P>. 05).
For the data collection in the oﬃce, data was complete
for all patients. Seventy-ﬁve percent of group 1 and 82% of
group 2 returned the completed questionnaire.
At all time points, the VAS scores for bloating and pain
werelower intheCO2 groupcomparedtotheroomairgroup
(Figures 1 and 2): patients experienced signiﬁcantly less
bloating at discharge, as well as one hour (P<. 001), three
hours(P<. 001),andsixhoursaftertheprocedure(P = .04).
Also, patients randomized to CO2 experienced signiﬁcantly
less pain at one hour (P<. 001) and three hours (P<. 001)
after the procedure. Overall pain summary scores for 24
hourswere signiﬁcantly lowerin theCO2 groupcompared to
the patients assigned to room air (3.6 ± 5.8v e r s u s6 .1 ± 7.4,
P = .014). Similarly, overall pain scores were signiﬁcantly
lower in patients randomized to CO2 versus room air (2.0 ±
3.8v e r s u s4 .0 ± 5.0, P = .007). The percentage of patients,
who did not experience any pain, was signiﬁcantly higher
in the group examined with CO2 up to 3 hours (Table 3).
Bloating was also signiﬁcantly less in the above-mentioned
time periods (P values between .023 to <.001).
The overall acceptance of the colonoscopy was excellent
in both groups. In the CO2 group, the overall satisfaction
score was 9.6 ± 0.7v e r s u s9 .3 ± 1.0 on a 10-point visual
analogue scale.
CO2 was continuously measured. There was no signif-
icant diﬀerence with respect to transcutaneous CO2 levels
Table 1: Baseline patient characteristics.
CO2 group
n = 110
Room air group
n = 109
P value
Age 58 ± 13 62 ± 12 .42
Sex Female:
62%
Female:
47%
.03
BMI 25 ± 4.72 6 ±4.4 .78
Comorbidity .36
ASA I 64.5% 61.5%
ASA II 29.1% 26.6%
ASA III 6.4% 11.9%
COPD 2.7% 2.8% .32
Irritable bowel syndrome 23.6% 12.8% .03
Indication .92
Screening 78.2% 79.9%
Surveillance 3.6% 4.6%
IBD 6.4% 4.6%
0
0.5
1
1.5
2
2.5
3
End Discharge 1h 3h 6h 24h
2.1 ±1.9
2.4 ±2 2.2 ±2.2 2.8 ±2.2
2 ±1.9
1.1 ±1.3
0.4 ±1.1
0.3 ±0.7 0.6 ±1 0.6 ±1.1 0.8 ±1.3
0.9 ±1.4
P0.3
P0.001 P0.001
P0.001
P0.04 P0.1
Air
CO2
Figure 1: Bloating over time depicted as visual analogue scale
scores.
between the CO2 and room air groups (pCO2 at the end
of procedure in CO2 group: 35.7 ± 4.3mmHg versus room
air group: 35.8 ± 6.5mmHg in group 2, Figure 3). In both
groups, there was a slight increase in CO2 from baseline
t ot h ei l e u m ;h o w e v e r ,t h eC O 2 values remained within
normal range. In all patients, including the known COPD
patients, the O2 saturation always stayed above 88% and
no ventilation, manual, or mechanical airway assistance was
required.
4.Discussion
This represents the ﬁrst large double-blinded randomized
controlled trial comparing the use of CO2 versus room air
in patients undergoing colonoscopy with propofol seda-
tion using continuous monitoring by capnography for all
patients. Our investigation provides compelling evidence
that CO2 insuﬄation compared with standard room air
signiﬁcantly reduces bloating and pain in patients undergo-
ing routine colonoscopy and stands in line with the review
reported by Dellon et al. [11] and several other studies
[9, 10, 15]. More important, the procedure is safe with
no signiﬁcant diﬀerences in CO2 measurements observed4 Diagnostic and Therapeutic Endoscopy
Table 2: Parameters of colonoscopy in CO2 and room air group.
CO2 group Room air group P value
Propofol 134mg ± 56 120mg ± 120 .9
Nasal oxygen substitution
if O2 saturation <90% 10% 20.2% .02
Ileum intubation rate 95.5%1 97.2%1 .22
Time to ileum 7.7 ±4.7min 6.7 ±4.1min .18
Withdrawal time 13.6 ±6.0min 13.3 ±6.1min .99
Intervention time 3.3 ±4.5min 3.2 ±4.6min .99
Polyps 68.2% 68.8% .11
>1cm 8.2% 7.3%
0.5–1cm 17.3% 16.6%
<0.5cm 63.6% 66.1%
Findings .77
Carcinoma 0.9% 1.8%
Relevant polyp2 10.9% 7.3%
Small adenoma3 34.5% 33.9%
Hyperplastic 13.6% 14.7%
CO2 (mmHg)
at start 33.4 ± 4.73 4 .6 ±5.1 .59
at ileum 37.3 ± 5.23 7 .0 ±5.2 .62
end of examination 35.2 ± 4.33 5 .6 ±6.0 .01
Maximal CO2 rise 4.2 ± 3.72 .9 ± 4.4 .77
10.9% stenosis (e.g., tumor, or sigmoid stenosis due to diverticulosis) in both groups, reaching coecum in 99% in both groups.
2Relevant polyps deﬁned as polyp >1cm, serrated, and villous ± high-grade dysplasia.
3Polyps size <1cm.
Table 3: Pain sensationassessed by VAS Score.
Time Insuﬄation %( n = absolute numbers) P value
VAS 0 VAS 1-2 VAS 3–5 VAS 6–10
End CO2 59 (65) 24.5 (27) 14.5 (16) 2 (2) .94
Air 57.7 (63) 23 (25) 16.5 (18) 2.8 (3)
Discharge CO2 73.6 (81) 14.5 (16) 10.9 (12) 0.1 (1) .23
(15–30min) Air 64.2 (70) 22 (24) 8.3 (9) 5.5 (6)
1h CO 2 68.8 (55) 22.5 (18) 8.8 (7) 0 <.0001
Air 36.4 (32) 34 (30) 18.2 (16) 11.4 (10)
3h CO 2 72.2 (57) 21.5 (17) 6.3 (5) 0 .015
Air 51.1 (45) 28.4 (25) 14.8 (13) 5.7 (5)
6h CO 2 73.8 (59) 20 (16) 6.2 (5) 0 .53
Air 66 (58) 22.7 (20) 10.2 (9) 1.1 (1)
24h CO2 87.5 (70) 7.5 (6) 5 (4) 0 .67
Air 86.4 (76) 11.4 (10) 2.3 (2) 0
between the two groups. This is of utmost importance, since
data are limited on this topic with safety still being debated
in sedated patients.
The setting of the present investigation has several
strengths. First, this study has a large sample size, notably
not selected without any exclusion, neither for pulmonary
d i s o r d e r so rf o r m e ra b d o m i n a ls u r g e r y .T h i sm a k e si t
possible to transfer our data to a screening population
without any restrictions (not even for COPD). Second, it
is one of the few [10] studies comparing CO2 and room
air use in a double-blinded randomized fashion. Third, all
patients were sedated, and the CO2 group was continuously
monitored. Fourth, only one endoscopist performed all
procedures, which removes technical skills as a potential
confounder. Fifth, the use of CO2 for routine colonoscopy
was associated not only with signiﬁcantly less pain and
bloating but also with superior patient tolerance. This
beneﬁt is particularly remarkable considering that the CO2Diagnostic and Therapeutic Endoscopy 5
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Figure 2: Pain over time depicted as visual analogue scale scores.
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Figure3:TranscutaneouslymeasuredCO2 valuesinCO2 androom
air group.
group had signiﬁcantly more women and more IBS patients
compared to the room air group. Of note, CO2 beneﬁts are
observed immediately after the sedation. The pain reducing
eﬀect seems is most apparent and profound in the ﬁrst
3 hours after the procedure, an observation that was also
seen in other studies [10]. Thereafter, a tendency of lower
pain perception persists. Stevenson et al. [16]s h o w e da
persisting beneﬁt even at 24 hours. The duration of this
beneﬁt might vary depending on the amount of air inﬂated
(whichisendoscopistdependent),theexaminationtime,and
the interventions, making it most valuable for patients with
large polyp resections.
Finally, the use of CO2 was not associated with a pro-
longed preparation time to set up or perform the procedure,
and there were no side eﬀects and no complications.
Abdominal pain after colonoscopy is common and
distressing for some patients and can cause even sick leave
[13].It is duetobowel distension bythe insuﬄating gas [12].
CO2 insuﬄation, as commonly used for establishing pneu-
moperitoneumduringlaparoscopicsurgery,hasalreadybeen
proposed and introduced in diﬀerent ﬁelds of endoscopy
[17–19]. This procedure has a potential of resulting in less
periprocedural pain, especially since new and easy to use
insuﬄators are on the market. Increasingly sophisticated
endoscopic procedures are currently being developed and
performed. Some of them are time consuming such as
endoscopic submucosal dissection (ESD) or therapeutic
endoscopic retrograde cholangiopancreaticography (ERCP).
Interestingly, an advantage for CO2 use was demonstrated
in patients undergoing ERCP as well as ESD with respect
to periprocedural pain [17, 18]. In a recently published
trial by Domagk et al. [19], it was shown that CO2 use for
balloon enteroscopy was not only less painful for patients,
but also associated with a signiﬁcantly deeper intubation
length of the small intestine. Another advantage is that
CO2 is less combustible in presence of stool or sub-optimal
bowel preparation and, therefore, potentially safer when
diathermy is being used. Moreover, it has advantages in
longer procedures to avoid overdistention of the colon.
However, the number of studies investigating the use of CO2
is limited and safety concerns with respect to respiratory
side eﬀects have been raised. This issue was assessed in three
studies. The ﬁrst including nonsedated patients undergoing
colonoscopy showed a slight, however, clinically irrelevant
(CO2 values within normal range) increase in end-tidal
pCO2 with CO2 insuﬄation compared to room air use
[20]. No diﬀerence in pCO2 was reported in the study of
Yamano et al. [10] in nonsedated patients. In another small
investigation, no diﬀerence was found between partially
sedated patients undergoing colonoscopy with room air
versus CO2. The authors concluded that CO2 insuﬄation
was safe [21]. However, this investigation included only 29
sedated patients undergoing colonoscopy with the use of
CO2. Here, we show the safety of CO2 insuﬄation in a large
sample of sedated patients.
It is well known and intuitive that the success of any
screening strategy is critically dependent on population
acceptance of the screening methods; eﬀorts to minimize
discomfort associatedwith colonoscopymaypositivelyinﬂu-
ence compliance. With the prospect of widespread col-
onoscopy screening for colorectal cancer in asymptomatic
populations, it is imperative to optimize patient comfort
and convenience as well as the quality of the examination
itself. Based on the ﬁndings of the present double-blinded,
randomized controlled trial, CO2 appears to be important to
reachthisgoalwithlessbloating,lesspain,andhigherpatient
satisfaction. The lack of awareness [1] of this compelling
technique should be changed over time, as endoscopists
are more and more convinced by growing evidence of the
usefulness and safety of CO2 insuﬄation.
5.StrengthsandLimitations
We would like to acknowledge the limitations of this study.
First, despite the randomized controlled study design, there
were some imbalances between the CO2 and room air group
with respect to gender and IBS. In fact, the CO2 group
contained more female and IBS patients. However, it is well
known that IBS and female patients usually have more pain6 Diagnostic and Therapeutic Endoscopy
and bloating after colonoscopy [22, 23]. Therefore, this will
b i a so u rﬁ n d i n g st o w a r d st h en u l lh y p o t h e s i sa n dt h et r u e
beneﬁt of CO2 colonoscopy may be even more important.
Second, the randomization was done with a dice for each
patient, and thus is theoretically prone to bias. However, a
study nurse did the randomization without any involvement
oftheinvestigators, and therefore, therisk ofbiasisminimal.
There are severalstrengths of thisstudy: ﬁrst, this investi-
gation was done in a double-blindedrandomized, controlled
fashion. Second, this is a large randomized patient sample;
more important, there are only few reports that have in-
vestigated the beneﬁt of CO2 in sedated patients with
continuous CO2 monitoring. Third, there were no exclusion
criteria in this study, and therefore, the generalizability
(external validity) ishigh. Most importantly, the present trial
addresses a very relevant and novel research questions and
hopefully will help changing practice patterns.
6.Conclusion
This study provides compelling evidence that CO2 insuﬄa-
tion is associated with signiﬁcantly less bloating and pain
during and after routine colonoscopy. Colonoscopy with
CO2 insuﬄation is safe as no signiﬁcant diﬀerences in
CO2 measurements were observed. Based on these data,
the routine use of CO2 insuﬄation for colonoscopy is
encouraged.
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